Tengion Adds $21 Million for Replacement Bladders

Tengion Inc., an East Norriton, Penn.-based regenerative medicine company focused on replacement bladders, has raised approximately $21 million in additional Series C funding, bringing the round total to $54 million. Safeguard Scientifics was joined on the round by return backers Bain Capital, Johnson & Johnson Development Corp., Deerfield Partners, Quaker BioVentures, Oak Investment Partners, HealthCap and L Capital Partners. The company had now raised over $140 million in total VC funding.

North AmericaUSBriefs